Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Santo Marsigliante

Showing results (101-110 of 105) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 105 results.
International Journal of Pharmaceutics|February 25, 2025
Slightly viscous oxidized alginate dispersions as vehicles for intranasal administration of the α-synuclein aggregation inhibitor Anle 138b in free form or encapsulated in solid lipid nanoparticlesRosanna Mallamaci, Stefano Castellani, Francesca Limosani, et al.
Bioinorganic Chemistry and Applications|September 20, 2023
Evaluation of the Antitumor Effects of Platinum-Based [Pt(<i>η</i><sup>1</sup>-C<sub>2</sub>H<sub>4</sub>-OR)(DMSO)(phen)]<sup>+</sup> (R = Me, Et) Cationic Organometallic Complexes on Chemoresistant Pancreatic Cancer Cell LinesErika Stefàno, Luca Giulio Cossa, Federica De Castro, et al.
International Journal of Environmental Research and Public Health|November 11, 2022
Trends of Phase I Clinical Trials in the Latest Ten Years across Five European CountriesDavide Di Tonno, Caterina Perlin, Anna Chiara Loiacono, et al.
Materials (Basel, Switzerland)|July 2, 2021
Oxidized Alginate Dopamine Conjugate: In Vitro Characterization for Nose-to-Brain Delivery ApplicationAdriana Trapani, Filomena Corbo, Gennaro Agrimi, et al.
Epidemiologia (Basel, Switzerland)|March 27, 2024
The Requirements of Managing Phase I Clinical Trials Risks: The British and Italian Case StudiesDavide Di Tonno, Laura Martena, Manuela Taurisano, et al.
Pageof 11

Showing results (101-110 of 105) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 105 results.
International Journal of Pharmaceutics|February 25, 2025
Slightly viscous oxidized alginate dispersions as vehicles for intranasal administration of the α-synuclein aggregation inhibitor Anle 138b in free form or encapsulated in solid lipid nanoparticlesRosanna Mallamaci, Stefano Castellani, Francesca Limosani, et al.
Bioinorganic Chemistry and Applications|September 20, 2023
Evaluation of the Antitumor Effects of Platinum-Based [Pt(<i>η</i><sup>1</sup>-C<sub>2</sub>H<sub>4</sub>-OR)(DMSO)(phen)]<sup>+</sup> (R = Me, Et) Cationic Organometallic Complexes on Chemoresistant Pancreatic Cancer Cell LinesErika Stefàno, Luca Giulio Cossa, Federica De Castro, et al.
International Journal of Environmental Research and Public Health|November 11, 2022
Trends of Phase I Clinical Trials in the Latest Ten Years across Five European CountriesDavide Di Tonno, Caterina Perlin, Anna Chiara Loiacono, et al.
Materials (Basel, Switzerland)|July 2, 2021
Oxidized Alginate Dopamine Conjugate: In Vitro Characterization for Nose-to-Brain Delivery ApplicationAdriana Trapani, Filomena Corbo, Gennaro Agrimi, et al.
Epidemiologia (Basel, Switzerland)|March 27, 2024
The Requirements of Managing Phase I Clinical Trials Risks: The British and Italian Case StudiesDavide Di Tonno, Laura Martena, Manuela Taurisano, et al.
Pageof 11